Recruiting
Phase 2

Solifenacin vs. Clonidine

Sponsor:

University of Arkansas

Code:

NCT01530373

Conditions

Hot Flashes

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

solifenacin

Clonidine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by University of Arkansas on 2025-04-29.